News and developments


Discover all the information about the research, development and marketing of immunotherapy treatments and natural food supplements for a healthier life.

Publication of findings on subcutaneous immunotherapy in the paediatric population


On 12 June, a study on the Beltavac® preparation was published in the Journal of Clinical Medicine, demonstrating the efficacy and good safety profile of subcutaneous immunotherapy in paediatric…


Read more

"Internationalisation Mentoring and Support” Programme


Probelte Pharma SLU, has received funding from the SME Internationalisation Mentoring and Support Programme. Among other costs, the company has used these funds to jointly fund dissemination and…


Read more

Probelte Pharma awarded the Plimsoll Certificate of Business Excellence 2023


Probelte Pharma SL, a manufacturer of allergen and bacterial immunotherapy products, has been awarded the Plimsoll Certificate of Business Excellence 2023. According to its latest…


Read more